Catalyst Wire Dossier Catalyst Wire Dossier

VBP15

· ReveraGen BioPharma, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VBP15, covering 2017-01-05 to 2017-01-05. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of VBP15 in Healthy Adult Subjects [Phase 1]

See pricing